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The Impact of Brief Clinical Interventions on Cardiovascular Reactions to Acute Stress 
 
Katherine Elizabeth O’Leary 
University of Connecticut, 2013 
 
 Stress is a major public health concern due to its’ harmful effects on physical and 
mental health.  An important goal for clinical health practitioners is to help patients 
reduce the psychological and physiological burden of stress.  The present study sought to 
examine the impact brief clinical interventions have on cardiovascular reactions to acute 
stress.  Additionally, we explored how depressive and anxiety symptomatology influence 
cardiovascular reactivity and recovery, and their moderating effects on treatment 
response to interventions.  To address these aims, subjects were randomized into one of 
three conditions (Acceptance and Commitment Therapy, Autogenic Training, Attention-
only Control group) prior to undergoing an acute psychosocial stress paradigm, the Trier 
Social Stress Test (TSST).  Psychosocial measures were given at baseline, and heart rate 
and blood pressure measurements were obtained at various time points throughout the 
protocol.  Our results indicated a time by group interaction for heart rate (HR) and 
diastolic blood pressure (DBP), demonstrating that brief interventions differentially 
affected heart rate and diastolic blood pressure over time.  Within the Autogenic Training 
group results showed that subjects with higher levels of depressive symptomatology had 
lower systolic blood pressure reactivity compared to those with lower levels of depressive 
symptoms.  Additionally, within the Autogenic Training group, greater recovery in both 
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systolic and diastolic blood pressure was found in subjects with higher levels of social 
anxiety.  Our results offer important implications for clinical assessment and intervention, 
particularly within the field of behavioral medicine.  
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Stress 
 Stress is defined as a real or implied threat to one’s psychological or physical 
integrity.  It evokes behavioral and physiological responses to psychosocial, 
environmental, and physical challenges, and thus can be viewed and measured from a 
variety of perspectives (Clark, Bond, & Hecker, 2007; Holmes & Rahe, 1967; Kiecolt-
Glaser, McGuire, Robles, & Glaser, 2002; Lazarus & Folkman, 1984; Logan & 
Barksdale, 2008).  Stress is a major public health concern. Over the past several decades, 
there has been a growing awareness of stress’s detrimental health effects, thereby 
necessitating a need for research into the pathways linking stress and health (Kudielka, 
Buske-Kirschbaum, Hellhammer, & Kirschbaum, 2004a).  
 The most common form of stress is acute stress.  In moderation acute stress is not 
harmful, however, if experienced frequently it can cause psychological and physical 
distress.  Stress has long been linked to maladaptive functioning and various 
psychopathologies, having been found to play a large causal and maintaining role in 
psychological disorders (Kessler, 1997; Nugent, Tyrka, Carpenter, & Price, 2011).  For 
example, individuals prone to experience acute stress are more likely to be over-aroused, 
irritable, and anxious.  Additionally, acute stress has been found to trigger panic attacks 
and psychotic episodes in those predisposed to thought disorders (Chrousos, 2009). 
 Several epidemiological studies have also emerged evidencing stress as a major 
psychosocial risk factor for various medical illnesses, such as cardiovascular disease 
(McEwen, 2000; Yusef et al., 2004).  Individuals who experience frequent acute stress 
are more prone to experience headaches, allergic reactions (e.g., asthma, eczema), 
hypertension, pain, and gastrointestinal symptoms (Black & Garbutt, 2002; Chrousos, 
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2009).  Currently, however, the exact mechanisms whereby stress exert its’ effects on 
human physiological and behavioral systems are not well understood (Epel et al., 2006). 
Allostasis and Allostatic Load 
 The concepts of allostasis and allostatic load are useful frameworks for 
investigating the detrimental health effects of stress.  Sterling and Eyer (1988) introduced 
allostasis as a concept that represents the active, adaptive process of regulatory 
physiological systems to physical, psychosocial, and environmental challenges. 
Stemming from allostasis theory, allostatic load, according to McEwen and Stellar 
(1993), is the wear and tear on the body caused by repeated activation of the stress 
response.  The concept of allostatic load is used to explain how frequent acute and 
chronic stress causes repeated activation of the stress response, resulting in damage and 
pathology (Clark et al., 2007; McEwen, 1998; Logan & Barksdale, 2008).  
 As McEwen (2000) explains there are four main conditions that lead to allostatic 
load: repeated frequency of the stress response, failure to habituate to repeated stressors, 
failure to turn off the stress response in a timely manner, and inadequate response leading 
to hyperactivity of other mediators.  Allostatic load is measured through a composite 
index of indicators of cumulative strain.  It is measured in physiological systems as 
chemical imbalances in the autonomic nervous system, central nervous system, and 
neuroendocrine immune system, and is thought to lead to disease through a number of 
routes.  For example, chemical messengers, such as cortisol and epinephrine are released 
as part of the stress response.  These chemicals can be affected by a variety of lifestyle 
factors (e.g., sleep, diet) and are generally beneficial.  However, when the body is 
overexposed to them, cumulative changes occur.  Repeated or dysregulated (i.e., over or 
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under-active) exposure to chemical mediators leads to tissue and organ specific effects, 
such as elevated blood pressure and increased heart rate.  These specific effects lead to 
subsequent outcomes, which are the actual disorders that arise from allostatic load 
(McEwen, 2003).  Examples of chronic illnesses thought to be associated with allostatic 
load are atherosclerosis, obesity, impaired physical capacity, anxiety, depression, and 
cognitive decline (Clark et al., 2007; Logan & Barksdale, 2008; Schulkin, 2004; Seeman, 
Singer, Rowe, Horwitz, & McEwen, 1997; McEwen, 2004). 
 Responses to acute stress may be mediated through a variety of behavioral 
pathways, including lifestyle factors such as smoking, substance use, obesity, and 
socioeconomic status (McEwen, 2000).  As we know, the brain perceives stress (whether 
real or imagined) and produces behavioral responses to cope with it.  These responses are 
determined by interpretations by the brain, which are greatly affected by psychosocial 
and individual differences, such as anxiety, depression, and social support (Logan & 
Barksdale, 2008; McEwen, 2002).  For example, one person may perceive a stressful 
event as threatening, while another may not.  Additionally, one may respond to an event 
to avoid a threat, where another may respond in such a way as to increase danger 
(McEwen, 2000).  In sum, how a person interprets and copes with an event determines 
behaviors and habits that are highly influenced by psychosocial and individual 
differences.  These behaviors make life more or less dangerous in the short-run and 
increase allostatic load over time.  
 In addition to behavioral pathways, direct physiological pathways also contribute 
to associations between psychosocial factors and the stress response.  Chronic, acute 
physical symptoms common in anxiety disorders and depressive illnesses, suggest that 
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physiological stress-related processes, particularly those involving the autonomic nervous 
system, greatly influence these conditions (American Psychiatric Association, 2000; 
Chrousos, 2009; Chrousos & Gold, 1992; Sullivan, Coplan, Kent, & Gorman, 1999).  
Currently, there is a discrepancy among the literature in how psychosocial factors affect 
the stress response.  For example, some studies have found positive psychological states 
and traits, anxiety, neuroticism, and negative affect to be associated with reduced 
hypothalamic-pituitary-adrenal (HPA) axis and cardiovascular reactivity to stress and 
poor recovery, while other studies have found hyperactive responses due to these factors 
(Logan & Barksdale, 2008; McEwen, 1998; McEwen, 2007; Tsigos & Chrousos, 2002).  
This inconsistency indicates that psychosocial factors may differentially influence 
individual stress responses (Chida & Hamer, 2008). 
 Stress, depression, anxiety, and cardiovascular disease. Within the allostatic 
load literature, the best-studied system in the human body is the cardiovascular system 
(McEwen, 1998).  Researchers have repeatedly linked stress to cardiovascular disease, 
one of the most frequent causes of death in the United States (Armario et al. 2003, 
Rosamond et al., 2007).  In addition, other psychosocial factors, including depression and 
anxiety, have been shown to increase one’s risk for cardiovascular disease.  There have 
been several large reviews about the links between depression, anxiety, and heart disease.  
For example, Kubzansky, Kawachi, Weiss, and Sparrow (1998) found that chronic 
anxiety was a major risk factor for coronary heart disease and Glassman and Shapiro 
(1997) demonstrated that depression was associated with increased mortality from 
coronary heart disease.  However, the mechanisms by which these relationships exist are 
not as well known (Logan & Barksdale, 2008). 
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 Anxiety and depression are believed to affect the heart through three main 
pathways: increasing ill-health behaviors, promoting atherogenesis via hypertension 
arising from chronic sympathetic nervous system activation and/or dysregulation, and 
triggering fatal coronary events.  In regards to acute stress, researchers have hypothesized 
that repeated episodes of acute psychological stress can result in elevated blood pressure, 
heart rate, and inflammatory processes (i.e., markers of allostatic load), increasing 
atherosclerotic plaques and stiffness of large arteries causing greater risk for 
cardiovascular disease (McEwen, 2002).  In fact, epidemiologic studies have found an 
association between heightened cardiovascular reactivity in response to stress, extensive 
progression of atherosclerosis, and incidence of ischemic heart disease and mortality 
(Black & Garbutt, 2002).  In sum, it is thought that anxiety and depression make 
individuals more susceptible to stress, resulting in repeated exposure to the stress 
response and an increase in allostatic load.  
 Currently, there is uncertainty in the literature over whether increased 
cardiovascular reactivity, poor cardiovascular recovery, or both lead to disease states.  
Additionally, research has shown mixed results on the effects depressive and anxiety 
symptomatology have on reactivity and recovery.  For example, studies investigating 
cardiovascular responses to acute psychosocial stressors have suggested that depression 
and anxiety are related to enhanced cardiovascular reactivity, as evidenced by increased 
blood pressure and heart rate (de Rooij, Schene, Phillips, Roseboom, 2010; Kibler & Ma, 
2004; Mausbach et al., 2005).  Others, however, have found negative associations 
implicating a hyporeactivity to acute psychosocial stress (Carroll, Phillips, Hunt, & Der, 
2007; Jezova, Makatsori, Duncko, Moncek, & Jakubek, 2004; Salomon, Clift, 
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Karisdottir, & Rottenberg, 2009).  For example, Heopniemi et al. (2007) found that 
delayed heart rate recovery and lower cardiac autonomic reactivity were associated with 
higher carotid atherosclerosis.  Mixed results in the literature may be in part due to an 
integrated stress response pattern, thereby supporting the concept of allostatic load that 
psychosocial factors could lead to different acute stress responses (Chida & Hamer, 
2008).  
 In sum, current explanations of stress have failed to adequately clarify its 
association with health and chronic illness.  The concept of allostatic load has 
applicability to subclinical and clinical psychological symptoms and suggests ways in 
which allostasis theory can be applied to the development of clinical interventions to 
increase resilience and the likelihood of better health outcomes (Logan & Barksdale, 
2008).  Further, responses to acute psychological challenge in the laboratory may not be 
considered of great clinical importance in and of themselves.  However, they adequately 
index the way individuals respond to ordinary psychological demands, thus offering a 
way to investigate how disturbed stress responses have pathophysiological significance in 
everyday life (Chida & Hamer, 2008; Salomon et al., 2009). 
Acute Stress Testing 
 As previously mentioned, acute stress has long been thought to play a role in the 
etiology of human psychopathologies, such as anxiety and depressive disorders, as well 
as medical illnesses, like cardiovascular disease (Black & Garbutt, 2002; Chrousos, 2009; 
Kessler, 1997; McEwen, 2000; Nugent et al., 2011; Yusef et al., 2004).  Due to the 
clinical significance of acute stress reactions, investigating the various ways stress 
impacts pathological and psychopathological mechanisms is of great importance 
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(McEwen , 2007). 
 In order to investigate these mechanisms, standardized procedures to induce acute 
psychosocial stress have been widely developed (Childs, Vicini, & De Wit, 2006).  One 
useful tool for this type of research has been laboratory-based mental stress testing.  This 
particular testing involves the measurement of acute physiological responses, such as 
cardiac, neuroendocrine, and autonomic nervous system functions, to standardized 
stimuli (e.g., public speaking, mental arithmetic tasks, emotionally demanding social 
interaction) (Chida & Hamer, 2008; Hellhammer & Schubert, 2012; Kirschbaum, Pirke, 
Hellhammer, 1993).  Although psychosocial stress testing involves artificial stimuli, it 
allows for the induction of consistent physiological responses with good test–retest 
reliability and offers a way to eliminate confounds, thereby elucidating causal factors 
(Brotman, Golden, & Wittstein, 2007; Chida & Hamer, 2008). 
 In contrast to protocols that involve physical exertion or pharmaceutical agents, 
acute psychosocial stress stimuli exert physiological, behavioral, and subjective stress 
responses (Kudielka, Wust, Kirschbaum, & Hellhammer, 2007).  In a meta-analysis of 
208 studies, Dickerson and Kemeny (2004) found that psychosocial stress tasks perceived 
as uncontrollable and that involve social-evaluative threat elicit the largest physiological 
response and longest recovery times.  Tasks that are defined as uncontrollable are those 
in which outcomes are perceived to be unaffected by individual behavioral responses. 
Social-evaluative threat involves the perception that others could negatively judge one’s 
task performance, thereby impacting social esteem, self-evaluation, and social goals 
(Kudielka et al., 2007).  The magnitude of changes in physiological parameters has been 
shown to depend on intensity of threat, context, and vulnerability, as well as protective 
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factors (Dickerson & Kemeny 2004). 
 Trier Social Stress Test. A variety of standardized procedures have been 
developed to induce acute psychosocial stress in a laboratory setting.  One of the most 
widely used protocols to study physiological responses to psychosocial stress is the Trier 
Social Stress Test (TSST) (Kirschbaum et al., 1993).  The TSST involves a public speech 
and mental arithmetic task that is performed in front of an evaluative panel and therefore, 
involves elements of uncontrollability and social evaluation.  It has been used in research 
with healthy study participants and clinical populations.  For example, the TSST has been 
successfully applied in studies with patients suffering from depressive illnesses, anxiety 
disorders (e.g., social phobia, posttraumatic stress disorder), burnout, exhaustion, 
functional somatic syndromes (e.g., chronic fatigue syndrome, fibromyalgia, irritable 
bowel syndrome), pain, and breast cancer survivors (Kudielka et al., 2007).  The TSST is 
one of the few available protocols that reliably elicits cardiovascular parameters, having 
been shown to produce moderate increases in both heart rate and blood pressure 
(Dickerson & Kemeny, 2004; Nater et al., 2005).  It has also been proven to produce 
moderate increases in cortisol and subjective reports of anxiety (Childs et al., 2006; 
Kudielka et al., 2004a; Williams, Hagerty, & Brooks, 2004). 
 The standardized TSST protocol lasts for a total of thirteen minutes. It involves a 
brief preparation period (3 minutes) followed by a test period during which subjects are 
asked to deliver a free speech (5 minutes).  Lastly, subjects are given a time to perform a 
mental arithmetic task (5 minutes).  They are asked to take over the role of a job applicant 
invited for an interview with the company’s selection committee.  The selection 
committee is comprised of 2-3 males or females unacquainted with the subject and has 
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been trained to respond in an unresponsive, neutral manner.  Selection committee 
members are introduced to subjects as being trained to monitor nonverbal behavior.  
Subjects are informed that their speech will be taped and video recorded for later 
analysis.  During the speech period, the selection committee members are given 
directions to respond to subjects in a standardized way. For example, if a subject ends the 
speech in less than five minutes, members are given prepared questions (e.g., what are 
your personal strengths? what are your major shortcomings?)  The mental arithmetic task 
involves asking the subject to serially subtract an uneven number from a larger number as 
fast and as accurately as possible. If the subject makes an error, they are asked to restart 
(Kirschbaum et al., 1993). 
 Over the past two decades, the TSST has shown to be a useful tool in basic, 
applied, and clinical psychobiological research.  Eliciting a range of psychobiological 
outcome variables, the TSST protocol has been utilized in a multitude of studies with 
children, adults, and the elderly to investigate the stress-disease connection (Kudielka et 
al., 2004a).  It has even recently been successfully applied in both group and virtual 
reality formats (Child et al., 2006; Jonsson et al., 2010).  Inducing endocrine and 
cardiovascular responses in 70–80% of subjects tested, the TSST procedure has been 
shown to significantly increase parameters such as free cortisol, total plasma cortisol, 
adrenocorticotropic hormone, catecholamines, growth hormone, prolactin, testosterone, 
blood pressure, heart rate, immune parameters, and measures of hemoconcentration and 
blood coagulation (Kirschbaum et al., 1993; Kudielka et al., 2007; Nater et al., 2005).  
 As previously mentioned, the TSST has been utilized in research investigating 
cardiovascular reactions to acute psychosocial stress in nonclinical, healthy populations.  
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For example, in a more recent study, Taylor et al. (2010) found a main effect of time 
showing a strong increase in heart rate, systolic blood pressure, and diastolic blood 
pressure from baseline to peak stress.  Additionally, these researchers found that although 
cardiovascular parameters decreased after the post-stress task, full recovery was 
incomplete, as evidenced by significant baseline to recovery differences.  In another 
study conducted by Nater et al. (2005), researchers found a significant difference in heart 
rate between the TSST and rest conditions and a positive relationship between salivary 
alpha amylase and sympathetic tone during stress.  In conclusion, the TSST has been 
reliably shown to induce acute physiological reactivity and incomplete recovery from 
psychosocial stress. 
 The TSST has also been successful utilized to investigate the impact psychosocial 
factors have on cardiovascular reactions to acute psychosocial stress in clinical 
populations and subjects with subthreshold psychological symptomatology.  For 
example, Chida and Hamer (2008) found that depressive mood or hopelessness exhibited 
significant associations with increased cardiovascular reactivity.  Regarding 
cardiovascular recovery after stress, these researchers found that general life stress and 
anxiety, neuroticism, and negative affect were associated with poorer cardiovascular 
recovery.  In contrast, a meta-analysis conducted by Kibler and Ma (2004), reported 
small, nonsignificant effect sizes linking depression to blood pressure reactivity and 
modest effect sizes for heart rate reactivity.  Additionally, York et al. (2007), Carrol et al. 
(2007), and Solomon et al., (2009) found a negative association between depressive 
symptoms and cardiovascular reactivity to mental stress.  In sum, and as previously 
mentioned, current research has shown mixed results on the effects psychological 
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symptoms, particularly depression and anxiety, have on physiological stress reactions.  
 The TSST has been utilized for well over two decades as a tool to study the 
mechanisms by which stress impacts physiological systems.  Given its success, the next 
important step is to investigate whether the TSST protocol can be utilized to investigate 
the efficacy of psychosocial interventions (Kudielka et al., 2007). 
Psychosocial Interventions 
 A key goal for clinical health practitioners is to help patients reduce the 
psychological and physiological burden of stress.  Over the past few decades, researchers 
have been investigating whether social, behavioral, and psychotherapeutic interventions 
can help practitioners achieve this goal (McEwen, 2007).  Studies have focused on 
psychosocial interventions aimed at managing stress, increasing resilience to stressful 
experiences, and treating physiologic responses to stress to improve health outcomes, 
such as cardiovascular function.  These nonpharmacological interventions target lifestyle 
factors (e.g., sleep, diet, physical activity), as well as interpersonal relationships, self-
efficacy, and self-esteem (Logan & Barksdale, 2008).  Others teach relaxation techniques 
to help one cognitively, behaviorally, and physiologically cope with, counteract, or alter 
the way in which one experiences and recovers from stressful experiences.  Psychosocial 
interventions can be offered in both long-term and brief formats, and are thought to offer 
a useful, nonpharmacological means to prevent the negative effects stress has in both 
healthy and clinical populations.  Two such psychosocial interventions are Autogenic 
Training (Schultz, 1932) and Acceptance and Commitment Therapy (Hayes, Strosahl, & 
Wilson, 1999).    
 Acceptance and Commitment Therapy. Acceptance and Commitment Therapy 
BRIEF CLINICAL INTERVENTIONS     12  
(ACT) is a therapeutic approach developed by Hayes et al. (1999) that focuses on 
increasing flexibility and willingness to experience stressful and anxiety provoking 
events and feelings.  It is a comprehensive psychotherapy treatment that can be delivered 
in both individual and group formats over both short and long-term.  ACT is based on 
relational frame theory, a contextual theory of language and cognition (RFT; Barnes-
Holmes, Hayes, & Roche, 2001).  Having grown out of the cognitive-behavioral 
tradition, ACT is considered a third-wave behavioral therapy.  However, unlike CBT, 
ACT makes no attempts to change unwanted thoughts or feelings; these are not 
necessarily viewed as problematic. As ACT teaches, acceptance and willingness, rather 
than control, is what leads a person to desired goals and improvements in quality of life. 
In order to attain goals and implement behavior change, ACT makes use of experiential 
methods and a number of therapeutic strategies (Hayes, Masuda, Bissett, Luoma, & 
Guerrero, 2004).  
 Many, including ACT followers, conceptualize forms of psychopathology as 
unhealthy efforts to control emotions, memories, thoughts, and other internal experiences 
(Hayes, Wilson, Gifford, Follette & Strosahl, 1996).  ACT teaches that attempts to 
control unwanted subjective experiences are counterproductive, resulting in an increase 
in psychological distress. ACT teaches positive psychological skills to counteract 
attempts to control, such as acceptance and cognitive defusion.  Acceptance is taught as 
an alternative to experiential avoidance and involves an active embrace of private events 
without attempts to change their frequency or form.  Cognitive defusion attempts to alter 
one’s sensitivity to undesirable thoughts (e.g., “I am being judged”) by reducing the 
literal quality of the experienced thought (e.g., I am having the thought “I am being 
BRIEF CLINICAL INTERVENTIONS     13  
judged”). Cognitive defusion techniques attempt to decrease the believability/reality of 
thoughts (Hayes, Luoma, Bond, Masuda, & Lillis 2006). 
 Although a relatively new psychotherapy treatment, ACT has shown empirical 
evidence for its effectiveness in treating a variety of psychopathologies (Forman, Herbert, 
Moitra, Yeomans, & Geller, 2007; Hayes et al., 2004).  In a recent review of the 
literature, Hayes et al. (2006) found that the average post-treatment effect size for 
randomized controlled clinical trials of ACT ranged from .55 to .99 and average follow-
up effect sizes ranged from .55 to .80.  Studies have shown promising results for its 
efficacy in treating depression (Forman et al., 2007; Zettle & Hayes, 1986; Zettle & 
Rains, 1989), anxiety (Woods, Wetterneck, & Flessner, 2006; Zettle, 2003), thought 
disorders (Bach & Hayes, 2002), substance abuse (Hayes et al., 2004), and workplace 
stress (Bond & Bunce, 2003).  
 For example, in a published study relevant to ours, Block (2002) examined the 
efficacy of ACT for social anxiety symptoms.  In that study, 39 college students with 
public speaking anxiety were semi-randomly assigned to six weeks of either ACT, 
cognitive-behavioral group therapy, or a no-treatment, waitlist control. Results showed 
that scores on social anxiety decreased for both treatment groups compared to the control 
condition.  In addition, willingness to engage in public speaking situations increased for 
both treatment conditions but only the ACT group showed significant decreases in 
behavioral avoidance (Block, 2002).  Additionally, in another study conducted by 
Forman et al. (2007), 101 university counseling center patients reporting moderate to 
severe levels of anxiety or depression were randomly assigned to traditional cognitive 
therapy or ACT (medium length of treatment = 15-16 sessions).  Results indicated that 
BRIEF CLINICAL INTERVENTIONS     14  
both cognitive therapy and ACT evidenced large, equivalent improvements in depression, 
anxiety, functioning difficulties, quality of life, life satisfaction, and clinician-rated 
functioning.  In regards to mechanisms of action, researchers found that changes in 
“observing” and “describing” one’s experiences appeared to mediate outcomes for 
cognitive therapy, whereas “experiential avoidance,” “acting with awareness,” and 
“acceptance” mediated outcomes for ACT (Forman et al., 2007). 
 ACT has also been shown to be a useful therapeutic approach in behavioral 
medicine populations.  ACT has been implemented with chronic pain (McCracken & 
Eccleston, 2006), cigarette smoking cessation (Gifford et al., 2004), diabetes (Gregg, 
Callaghan, Hayes, Glenn-Lawson, 2007), and epilepsy (Lundgren, Dahl, & Hayes, 2004) 
patients.  One hypothesized mechanisms by which ACT benefits medical patient 
populations is through its emphasis on emotional acceptance rather than suppression. 
Research has shown that certain emotion-regulation processes, such as rumination and 
worry, increase distress and prolong physiological stress responses.  In contrast, 
acceptance-oriented coping strategies promote efficient cardiovascular habituation and 
recovery from stress (Campbell-Sills, Barlow, Brown, & Hofmann, 2006; Low, Stanton, 
& Bower, 2008).  
 For example, in a recent study conducted by Low et al. (2008), 81 participants 
were randomly assigned to write about ongoing stressful experience while either (1) 
evaluating the appropriateness of their emotional response, (2) attending to their emotions 
in accepting way or, (3) simply describing the objective details of their experience. 
Results indicated that writing about emotions in an evaluative way led to less efficient 
heart rate habituation and recovery than processing emotions in an accepting manner 
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(Low et al., 2008).  In another study by Campbell-Sills et al. (2006), researchers 
compared subjective and physiological effects of emotional suppression and acceptance 
in 60 subjects diagnosed with anxiety and mood disorders. Subjects were randomly 
assigned to either a group that listened to a rationale for suppressing emotions or a group 
that listened to a rationale for accepting emotions.  Subjective distress, heart rate, skin 
conductance level, and respiratory sinus arrhythmia were measured before, during, and 
after watching an emotion-provoking film during which the subjects were told to apply 
the learned instructions.  Results indicated that both groups reported similar levels of 
subjective distress during the film but that the acceptance group displayed less negative 
affect during the post-film recovery period.  Additionally, the suppression group showed 
an increased heart rate while the acceptance group showed a decreased heart rate in 
response to the film (Cambell-Sills et al., 2006).  In sum, there is solid and growing 
evidence that ACT is a beneficial intervention for both nonclinical and clinical 
populations.  
 Autogenic Training. Autogenic Training (AT) is a relaxation technique 
performed through passive concentration aimed at promoting relaxation and stress relief. 
Johannes Schultz, a German psychiatrist and neurologist, first presented AT in the 1930s. 
Schultz theorized that mentally connecting with parts of one’s body produces a state 
similar to that experienced under hypnosis and found that his technique of AT improved 
health and reduced stress in many of his patients (Schultz, 1932).  AT was further 
developed by Wolfgang Luthe and in its’ current form involves a series of statements 
aimed at reducing autonomic arousal (Linden, 1990; Luthe, 1969; Luthe & Schultz, 
1959).  AT teaches passive concentration on breathing, heartbeat, warmth, and heaviness 
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of body parts, and is normally taught and learned over a period of eight to ten weeks 
(Kanji, 1997; Morgan & Jorm, 2008).  AT is based on three main principles: reduction of 
exteroceptive and proprioceptive afferent stimulation, mental repetition of 
psychophysiologically adapted verbal statements, and mental activity conceived as 
'passive concentration' (Schulz, 1932; Kanji, 1997).  Some believe that AT may be 
superior to other behavioral relaxation techniques because it teaches individuals how to 
self-regulate physiological responses and, once learned, can be practiced without a 
therapist (Cowings, Toscano, Timbers, Casey, & Hufnagel, 2005; Schlamann, Naglatzki, 
de Greiff, Forsting, & Gizewski, 2010).    
 AT offers individuals a way in which to exert calming effects on their mind and 
body.  A meta-analysis by Stetter & Kupper (2002) on 60 randomized controlled trials 
found main effects in the range of medium-to-large effect sizes for pre-post comparisons 
of disease specific AT-effects.  They also found that unspecific AT-effects, such as 
mood, cognitive performance, physiological variables, and quality of life, were larger 
than main effects. Analyzing study populations separately, they found positive effects in 
the medium effect size range for migraines, hypertension, coronary heart disease, pain 
disorder, anxiety disorders, mild-to-moderate depression, and functional sleep disorders. 
However, they also observed that AT had not been compared with cognitive or exposure 
therapy or psychopharmacological treatments for depression and anxiety, and that 
comparison with medical treatments were rare.  In sum, Stetter & Kupper (2002) stated 
that AT results in medium-to-large clinical main effects that are stable at follow-up, but 
further comparison to other efficacious treatments are needed. 
 In a randomized controlled trial conducted by Kanji, White, & Ernst (2004a) 
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researchers observed the effectiveness of AT in reducing anxiety in a group of nursing 
students.  The study investigated the differential effects interventions (e.g., AT, attention 
control group, time control group) have on anxiety, burnout, and cardiovascular 
parameters.  They found a greater reduction of state and trait anxiety in the AT group 
than in other groups immediately after treatment but no differences between groups for 
burnout.  They also found that the AT group had the greatest reduction immediately after 
treatment in systolic blood pressure, diastolic blood pressure, and heart rate.  In regards to 
depressive symptoms, Krampen (1999) compared AT with individual psychotherapy and 
delayed treatment in 55 adults with depressive disorders. Subjects were randomized to 
one of three groups: individual psychotherapy alone, AT and individual psychotherapy, 
and waitlist control.  In long-term follow-up (3 years), results showed that AT in 
combination with individual psychotherapy resulted in more positive effects than 
psychotherapy alone, such as lower rates of relapse and treatment reentry, and reductions 
in depressive and somatic symptoms.  In another study with 134 adults with minor, 
subclinical depressive symptoms, Farne and Gnugnoli (2000) found that AT improved 
depressive mood after three months significantly more than in the control group.  These 
results demonstrate that AT may be a beneficial intervention for patients suffering from 
minor to moderate psychological pathology.  
 Studies have also found AT to have positive effects in medical patients with high 
blood pressure, early stage cancer, irritable bowel syndrome, migraines, and acute 
anxiety, (Aivazyan, Zaitsev, & Yurenev, 1988; Herbert & Gutman, 1983; Hidderley & 
Holt, 2004; Kanji, White, & Ernst, 2004b; Kanji, White, & Ernst, 2006; Labbe, 1995; 
Shinozaki et al., 2010; Ter Kuile, Spinhoven, Linssen, Zitman, & Van Dyck, 1994; 
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Zsombok, Juhasz, Buravari, Vitrai, & Bagdy, 2003). In regards to cardiovascular 
function, Atkinson et al. (2000) found that AT showed a greater reduction immediately 
after treatment in blood pressure and heart rate measures compared to a control group.  In 
59 patients undergoing coronary angioplasty, Kanji et al. (2004b) found significant 
reductions in anxiety in AT group at two and five months post surgery.  Additionally, in a 
pilot study of early stage cancer patients, Hidderley and Holt (2004) found that AT 
resulted in a decrease in anxiety and depression, and an increase in immune responses (as 
measured by T and B cell markers).  In sum, AT has shown to be a beneficial relaxation 
intervention in both nonclinical and clinical populations.  
 As the literature shows, both Acceptance and Commitment Therapy and 
Autogenic Training have been applied successfully in a variety of study populations. 
However, to date, ACT and AT have yet to be applied in brief formats to investigate the 
differential, and possible buffering, effects these interventions have on physiological 
stress reactions to acute psychosocial stress. 
Present Study 
 As previously mentioned, allostatic load provides a conceptual and 
methodological basis for elucidating behavioral and physiological mechanisms of stress. 
It offers a mechanistic framework for investigating how genes, early life experiences, 
current environments, interpersonal relationships, and lifestyle factors join to affect the 
structure and function of the human body.  Most importantly, it offers a basis for 
understanding the etiology of systemic illnesses.  Allostatic load allows one to consider 
the multiple pathways of cause and effect with consideration of interactions between 
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organ systems, for example, the link between cardiovascular disease and anxiety and 
depressive symptoms (Juster et al., 2011; McEwen, 2000). 
 The primary aim of the current study was to investigate physiological stress 
reactions to an acute psychosocial stressor and the possible buffering effects brief 
interventions have on these reactions.  To address this aim, participants were randomized 
to one of three intervention conditions (Acceptance and Commitment Therapy (ACT), 
Autogenic Training (AT), or Attention-only Control condition) prior to undergoing an 
acute psychosocial stress protocol (Trier Social Stress Test; TSST). 
 In addition, for clinical assessment and intervention purposes, we believed it was 
highly warranted to investigate how certain psychological symptoms (e.g., anxiety and 
depression) influence acute physiological stress reactions and if they moderate the 
treatment response.  To address these exploratory aims, participants were asked to 
complete a variety of psychosocial measures, including measures of anxiety and 
depression, prior to the TSST.  
  We hypothesized that brief interventions (ACT and AT) would have differential 
effects on physiological stress reactions.  We believed that the experimental conditions 
(ACT and AT) would buffer the stress response and result in lower reactivity and greater 
recovery following the TSST.  More specifically, we thought Autogenic Training would 
be superior to the Acceptance and Commitment Therapy condition, and that both would 
be superior to the Control Condition.  We also hypothesized that anxiety (social anxiety, 
trait anxiety, anxiety sensitivity) and depressive symptoms would impact the 
physiological stress response in that higher symptomatology would result in greater 
reactivity and lower recovery following the TSST.  Lastly, we hypothesized that anxiety 
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and depression would moderate the treatment response. 
Method 
Participants 
 Data for the present study was collected as a part of a larger study exploring the 
effects brief interventions have on subjective and objective stress reactions.  Participants 
were drawn from the undergraduate population at the University of Connecticut, Storrs 
from Fall 2009 to Spring 2011.  Participants were recruited through the Psychology 1100 
and 1103 participant pool for which they registered to gain experience regarding the 
experimental method while earning credits as unpaid participants in psychological 
research.  For inclusion, participants were between 18-25 years of age and were able to 
provide informed consent.  There were no additional inclusion or exclusion criteria. A 
total of 123 students consented and data was collected on all of them.  The average age 
was 19.08 (1.02) years; 66.67% were women, and 67.5% were White. 
Procedure 
 The Institutional Review Board at the University of Connecticut approved the 
study, which was a randomized controlled trial utilizing a repeated measures cohort 
design.  Participation involved one, three-hour visit to the lab. The study was broken 
down into three main assessment points (see Appendix A): 
 Time 1 lasted approximately 75 minutes. Upon arrival to the lab, informed 
consent was obtained.  Following this process, participants completed a Demographic 
and Medical History Questionnaire, along with baseline physiological (heart rate and 
blood pressure) and psychological assessments (Anxiety Sensitivity Index, Beck 
Depression Inventory-II, Liebowitz Social Anxiety Scale, Spielberger State-Trait Anxiety 
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Inventory- Trait Form).  Next participants were randomized to one of three conditions. 
The first condition involved an Acceptance and Commitment Therapy intervention, the 
second condition involved an Autogenic Training intervention, and the third condition 
was an Attention-only Control group (described in further detail below). All interventions 
lasted twenty minutes. 
 Time 2 lasted approximately 45 minutes.  It began immediately after the 
intervention with a second physiological assessment (heart rate and blood pressure). 
Next, participants completed the Trier Social Stress Test (TSST; described in further 
detail below).  
 Time 3 lasted approximately 60 minutes. It began immediately following the 
conclusion of the TSST with a third physiological assessment (heart rate and blood 
pressure).  Participants were then debriefed on the aims of the study. They were informed 
that the recording equipment was not turned on and that their performance was not 
recorded using any audiovisual equipment.  They were also introduced to the two 
confederates who made up the selection committee.  Subjects were told that these 
individuals were undergraduate research assistants who were trained to play roles. 
Following the debriefing, all participants engaged in a period of rest before a final 
physiological assessment (heart rate and blood pressure) was conducted.  At the 
conclusion of the study, participants were given time to ask questions and thanked for 
their participation. 
Physiological Measures 
 Blood pressure and heart rate were collected non-invasively utilizing a 
commercially available monitor (Omron Digital Blood Pressure Cuff; model number 
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HEM-907XL; White & Anwar, 2001). The device was used in accordance with the 
directions provided with the equipment.  Participants were asked to sit comfortably and 
upright in a chair while the monitor’s cuff was placed around their upper arm to 
simultaneously measure blood pressure and heart rate. One reading per time point was 
made. 
Psychological Measures 
 Anxiety Sensitivity Index. The Anxiety Sensitivity Index (ASI; Reiss, Peterson, 
Gursky, & McNally, 1986) is a 16-item self-report questionnaire that assesses fear of 
anxiety sensations.  Subjects rate scale items on a 5-point scale (0 = very little; 4 = very 
much) to indicate to what extent they agree with statements such as: ‘It scares me when I 
feel faint,’ ‘It is important for me to stay in control of my emotions,’ and ‘Other people 
notice when I feel shaky.’  The scale yields one total summary score ranging from 0 to 
64. Various ASI reliability studies revealed a high degree of internal consistency with 
Cronbach’s alpha statistics ranging from .80 to .90.  The ASI has been shown to measure 
a stable personality trait, as one study reported a three-year test-retest correlation of .71 
(Maller & Reiss 1992; Reiss 1991).  The ASI has also shown excellent diagnostic 
criterion validity.  Scores have been found to be strongly associated with fearfulness, 
panic attacks, and subjective anxiety during biological challenge (Reiss et al., 1986; 
Reiss, Peterson, & Gursky, 1988; Peterson & Sacks 1987; Maller & Reiss 1987).  In the 
present study, the ASI was shown to have good internal consistency (average α = .86). 
 Beck Depression Inventory-II. The Beck Depression Inventory-II (BDI-II; 
Beck, Steer, & Brown, 1996) is a 21-item self-report measure that assesses depressive 
symptoms.  Subjects rate scale items on a 4-point scale (0-3) to indicate which statement 
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in each group best describes the way they have been feeling during the past two weeks. 
Items measure both cognitive (e.g., self-dislike, guilt) affective (e.g., sadness, crying), 
and neurovegetative (e.g., appetite, sleep) symptoms.  The scale yields one total summary 
score ranging from 0-63; higher scores indicate increasing intensity of depressive 
symptoms. The BDI-II is one of the most widely used depression rating scales for both 
clinical and research purposes.  It has demonstrated excellent internal consistency with an 
alpha coefficient of .92, excellent concurrent validity, construct validity, and test-retest 
reliability across studies (Beck, Steer, Ball, & Ranieri, 1996).  In the present study, the 
BDI-II had an average α of .33. 
 Demographics and Medical History Questionnaire.  The Demographic and 
Medical History Questionnaire was created specifically for this study.  It gathers basic 
demographic data, such as date of birth, and race and ethnicity, as well as medical 
information necessary for analyses of physiological data.  Questions include diagnoses of 
mental and/or physical illness, medication(s), weight and height, substance use, and 
exercise.  
 Liebowitz Social Anxiety Scale. The Liebowitz Social Anxiety Scale (LSAS; 
Liebowitz, 1987) is a 24-item self-report questionnaire that measures respondents’ fear 
and avoidance of social situations, such as social interactions (e.g., going to a party, 
meeting strangers) and public performances (e.g., giving a prepared oral talk, speaking up 
at a meeting).  Each item is rated on two 4-point scales, the first measures fear/anxiety 
and the second measures avoidance.  Scores range from 0 (no fear/never avoid) to 3 
(severe fear/usually avoid).  The scale yields one total summary score ranging from 0-
144; higher scores indicate increasing intensity of social anxiety.  Total scores have been 
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shown to adequately differentiate between individuals with and without social anxiety 
disorder (i.e., social phobia). The LSAS has demonstrated adequate reliability and 
validity. The scale has shown excellent internal consistency with an alpha coefficient of 
.95. It also has good test-retest reliability, as well as good discriminant and convergent 
validity (Heimberg et al., 1999; Fresco et al., 2001; Baker et al., 2002). The LSAS was 
shown to have good internal consistency in the present study (average α = .85). 
 Spielberger State-Trait Anxiety Inventory. The Spielberger State-Trait Anxiety 
Inventory (STAI; Spielberger, Gorsuch, & Lushene, 1970) is a self-report questionnaire 
that consists of two 20-items subscales.  The state subscale (“state anxiety”) assesses 
momentary anxiety and includes statements such as ‘I feel secure,’ ‘I am jittery,’ and ‘I 
feel confused.’ The trait subscale (“trait anxiety”) assesses the stable tendency to 
experience anxiety and includes statements such as ‘I lack self-confidence,’ ‘I feel 
nervous and restless,’ and ‘I feel rested.’ For the state subscale, subjects are asked to 
answer based on how they feel at that present moment.  For the trait subscale, subjects are 
asked to answer based on how they generally feel.  Scores for individual items range 
from 1 (not at all/almost never) to 4 (very much so/almost always), with total scale scores 
ranging from 20-80. Higher scores indicate higher degrees of anxiety.  The STAI is one 
of the most frequently used self-report measures of state and trait anxiety with adequate 
reliability and validity.  The trait subscale has shown good internal consistency (median 
alpha coefficient .90) and adequate test-retest reliability (ranging from .73 to .86).  The 
state subscale has shown good internal consistency as well (median alpha coefficient .93) 
and expected low test-retest reliability given it assesses momentary anxiety (scores 
ranging from .16 to .62; Spielberger, 1983).  In this study, we only utilized the trait 
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subscale (STAI- Trait), which was shown to have excellent internal consistency in the 
present study (average α = .92). 
Experimental and Control Conditions 
 ACT intervention. This experimental condition involved exercises drawn from 
Acceptance and Commitment Therapy (ACT; Hayes, Strosahl, & Wilson, 1999).  This 
condition involved the researcher explaining and defining the main principles of ACT 
(e.g., experiential avoidance and cognitive fusion).  It also utilized time to teach strategies 
for coping with anxiety (e.g., acceptance and defusion techniques) and involved 
experiential exercises (e.g., envisioning emotions as waves and observing and labeling 
thoughts).  
 AT intervention. This experimental condition involved Autogenic Training (AT; 
Schultz, 1932), which is a self-relaxation procedure.  This condition involved the 
researcher offering a rationale for Autogenic Training.  The researcher than lead 
participants through a series of statements, which facilitated a passive concentration on 
bodily perceptions (e.g., heaviness in the limbs, feelings of warmth) aimed at relieving 
tension and stress.  
 Attention-only Control. This control condition involved an attention-only task. 
The researcher read aloud from a fictional book called, “Journey Under the Sea,” which 
is a book from “Choose Your Own Adventure” series (Published by Chooseco LLC). 
These books are interactive and ask readers to make decisions throughout the story.  The 
participants were involved in giving their input in choosing the various story lines, 
therefore ensuring engagement in the task. 
Challenge Task 
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 Trier Social Stress Test protocol. As previously described, the Trier Social 
Stress Test (TSST; Nater et al., 2005) is a widely utilized standardized protocol for the 
induction of psychological stress in a laboratory setting.  In this study, the TSST began 
with the researcher leading the participant to a different room, where they were 
introduced to two confederates sitting at a table (trained undergraduate research assistants 
posing as a selection committee).  In the room, there was a podium where the participant 
was instructed to stand, along with a video camera and a tape recorder.  The researcher 
explained the task they were about to perform which involved assuming the role of a job 
applicant who is invited for an interview.  Participants were told that after having a few 
minutes to prepare, they would be asked to give a 5-minute speech about why they are 
the best person for the job position.  Participants were told that the selection committee 
was specially trained to monitor nonverbal behavior, that a video recording of their 
speech would be conducted, and that a voice frequency analysis of nonverbal behavior 
would be performed at a later date.  After the instructions were read, participants were led 
back to room A, where they were given three minutes to prepare a speech.  After their 
time was up, they were led back into room B where they were asked to deliver their 
speech.  After five minutes, the committee interrupted the participant and asked him/her 
to serially subtract the number 13 from 1,022 as fast and as accurately as possible. On 
every failure the participant had to restart at 1,022 with one member of the committee 
interfering with, “Stop – mistake – start over at 1,022, please.”  The participant was given 
five minutes to complete this task before being led back to room A for further assessment 
and debriefing. 
Data Analytic Plan 
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 All data analyses were performed using SPSS version 19.0 (SPSS, Inc., 2010).  
We first conducted exploratory data analyses to assess demographic composition of the 
sample and to determine whether variables of interest met assumptions of normality. 
Bivariate correlation matrixes were computed using data from the Demographic and 
Medical History Questionnaire to determine whether potential covariates should be 
controlled for in analyses.  ANOVA’s were conducted to assess baseline differences 
between measures.  Where appropriate, Tukey’s HSD post hoc comparisons were used 
for a posteriori comparisons among means.  Three participants were excluded: one 
participant was excluded based on age, and two others did not complete the study in its 
entirety due to the severity of their baseline psychological symptoms and the moderately 
stressful nature of the TSST. 
 To test whether brief interventions have differential effects on physiological stress 
reactions over time, 3 (experimental condition) x 4 (time) repeated measures ANOVAs 
and ANCOVAs were conducted for heart rate, systolic blood pressure, and diastolic 
blood pressure.  To test whether depression and/or anxiety moderate the treatment 
response, ANCOVAs were conducted utilizing total scores on the ASI, BDI-II, LSAS, 
and STAI-Trait as moderator variables, entered as covariates into analyses.  To explain 
significant three-way interactions, ANCOVAs were conducted to describe depression and 
anxiety effects for each treatment group separately. ANCOVAs were also conducted to 
demonstrate intervention effects for low and high anxiety and depression separately. 
Median splits were utilized to dichotomize psychosocial variables in these analyses. 
Reactivity scores were calculated as the change between time 2 and time 3 cardiovascular 
measures.  Recovery scores were calculated as change scores between time 3 and time 4. 
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Parameter estimates were used to graph 3-way interactions with continuous variables. 
This allowed us to best graphically illustrate psychological indices as moderator variables 
in a nonclinical sample; high and low BDI-II, STAI-Trait, ASI, and LSAS variables were 
defined as follows: high = 1 SD above the mean, low = 1 SD below the mean.  
 All analyses were first run with four time points including baseline cardiovascular 
measures (time 1, time 2, time 3, time 4).  Separate analyses were then run on only three 
time points (time 2, time 3, time 4) with baseline cardiovascular values as covariates to 
control for baseline effects on reactivity and recovery.  Next, a series of analyses were 
conducted to determine the influence of potentially confounding factors on baseline 
cardiovascular measures.  Any demographic variable associated with baseline HR, SBP, 
or DBP at p ≤ .1 was considered a potential confound, and thus, entered as a covariate in 
relevant analyses. In sum, bivariate correlations revealed that exercise was a potential 
confound for baseline HR; drug use, alcohol consumption, gender, and BMI were 
potential confounds for baseline SBP; and drug use, smoking, and BMI were potential 
confounds for DBP.  Experimenter and time of day were also used as covariates to 
control for between group differences observed in baseline cardiovascular measures. 
Analyses were finally run with baseline cardiovascular values and the above-mentioned 
relevant physiological covariates.  Reported results were corrected by Greenhouse-
Geisser procedure where appropriate (violation of sphericity assumption), indicated by 
uneven degrees of freedom (Greenhouse and Geisser, 1959; Vasey and Thayer, 1987). 
Throughout, partial eta2 is reported as a measure of effect size. 
 Lastly, in order to investigate whether depressive and/or anxiety symptoms are 
associated with greater reactivity and lower recovery following the TSST, partial 
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correlations were conducted.  Intervention group was entered as covariate in all analyses 
to control for possible intervention effects. In our analyses, power ranged from 0.4 to 1.0. 
Results  
Participant Characteristics  
 Demographic characteristics by group and gender of those included in the 
analyses are presented in Tables 1-2. Participants included 120 college undergraduate 
students. The average age of participants was 19.08 years (SD = 1.02).  Two-thirds were 
female (n = 80).  All participants reported race/ethnicity as follows: 67.5% White, Non-
Hispanic; 12.5% Black/African American; 11.7% Asian; 6.6% Hispanic/Latino; 
Biracial/Multiracial 1.6%.  Seventeen individuals (14.2%) reported a mental health 
diagnosis (e.g., depression, anxiety) and nine individuals (7.5%) reported a chronic 
medical condition (e.g., asthma, diabetes).  Thirty-three individuals (27.5%) reported 
daily medication use (e.g., birth control, psychiatric medications).  Over half the sample 
(57.5%) reported alcohol consumption, 5% reported cigarette smoking, and 13.3% 
engaged in illicit drug use (e.g., marijuana).  Average body mass index was 23.44 kg/m2 
(SD = 4.02) and 55% reported engagement in regular physical activity. 
Descriptive Statistics for Study Measures 
 Descriptive statistics for all physiological measures at each time point by group 
are detailed in Table 3 and for each time point by gender in Table 4.  Statistics for 
psychological measures are also included. Baseline statistics are reported below. 
 Baseline physiological measures. Mean baseline heart rate (bpm) for all 
participants (n = 120) was 76.47 bpm (SD = 14.72).  ANOVAs were conducted to 
determine significant between group differences in baseline heart rate.  A significant 
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difference (p ≤ 0.05) was found, such that the AT intervention group (mean = 81.78 bpm) 
had a higher mean baseline heart rate compared to the ACT (mean = 73.60 bpm) and 
Control (mean = 74.03 bpm) groups.  
 Mean baseline systolic blood pressure (mmHg) for all participants (N = 120) was 
126.11 mmHg (SD = 14.60).  ANOVAs were conducted to determine significant between 
group differences in baseline systolic blood pressure.  No differences between 
intervention groups were found. 
 Mean baseline diastolic blood pressure (mmHg) for all participants (n = 120) was 
72.97 mmHg (SD = 8.90).  ANOVAs were conducted to determine significant 
differences between intervention groups in baseline systolic blood pressure.  A significant 
group difference (p ≤ 0.05) was found between the AT (mean DBP was 76.43 mmHg, SD 
= 8.57) and Control (mean DBP was 69.45 mmHg, SD = 8.76) groups.  
 Psychological measures. All psychological measures were administered once at 
baseline.  ANOVAs were conducted and no group differences were found among any of 
the psychological measures.  Mean score for the BDI-II was 8.34 (SD = 6.87), for the 
LSAS was 35.50 (SD = 21.60), for the STAI-Trait was 38.88 (SD = 10.67), and for the 
ASI was 19.65 (SD = 9.98).  
Hypothesis 1: Impact of Brief Clinical Interventions  
 For heart rate (HR), repeated measures ANOVAs revealed a main effect of time 
(F (2.30, 269.55) = 59.58, p ≤ .001, η2 = .34) as well as a time by group interaction (F 
(4.61, 269.55) = 3.82, p = .003, η2 = .06).  Post hoc tests indicate a group differences in 
HR at baseline among AT and ACT (p = .032), and AT and Control groups (p = .045), 
but at no other time point.  Thus, after controlling for baseline HR, repeated measures 
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ANCOVAs revealed no effects.  However, once relevant covariates (exercise, time of 
day, experimenter) were controlled for along with baseline HR, a main effect of time 
reemerged (F (1.91, 216.08) = 3.25, p = .04, η2 = .03), demonstrating a significant change 
in HR over time.  
 For systolic blood pressure (SBP), repeated measures ANOVAs revealed a main 
effect of time (F (2.88, 337.22) = 53.08, p ≤ .001, η2 = .31).  Repeated measures 
ANCOVAs, with baseline SBP as a covariate, revealed no main or interaction effects. 
Similarly, controlling for relevant covariates (drug use, alcohol, gender, BMI, time of 
day, experimenter) along with baseline SBP did not reveal any significant effects. 
 For diastolic blood pressure (DBP), repeated measures ANOVAs revealed a main 
effect of time (F (2.9, 338.72) = 43.86, p ≤ .001, η2 = .27) as well as a time by group 
interaction (F (5.79, 338.72) = 2.39, p = .03, η2 = .04).  Post hoc tests indicate a group 
differences in DBP at baseline among the AT and Control groups (p = .001).  Controlling 
for baseline DBP revealed no main or interaction effects.  Additionally, controlling for 
relevant covariates (drug use, smoker, BMI, time of day, experimenter) along with 
baseline DBP did not reveal any significant effects. 
Hypothesis 1a: Depressive and/or Anxiety Symptoms as Treatment Moderators 
 Depression (Beck Depression Inventory-II).  For HR, repeated measures 
ANCOVAs, with total BDI-II score entered as a covariate to test for moderation, revealed 
a main effect of time (F (2.27, 258.18) = 20.10, p ≤ 0.001, η2 = .15) as well as a time by 
group interaction (F (4.53, 258.18) = 2.47, p = .04, η2 = .04).  Post hoc tests indicate a 
group differences in HR at baseline among AT and ACT (p = .032), and AT and Control 
groups (p = .045), but no group differences at any other time point.  Thus, controlling for 
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baseline HR revealed no main or interaction effects.  However, once relevant covariates 
(exercise, time of day, experimenter) were controlled for along with baseline HR, a main 
effect of time reemerged (F (1.89, 208.20) = 3.60, p = .031, η2 = .03), demonstrating a 
significant change in HR over time. 
 For SBP, repeated measures ANCOVAs, with total BDI-II score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.82, 321.99) = 25.77, 
p ≤  0.001, η2 = .18) as well as a 3-way time by group by depression interaction (F (5.65, 
321.99) = 2.24 p = .043, η2 = .04), which remained after controlling for baseline SBP (F 
(3.8, 214.4) = 2.46,  p = .05, η2 = .04); see Figures 1-5.  The 3-way interaction 
demonstrates that across time points, SBP is affected differently among intervention 
groups depending on level of depression.  In the AT group, subjects with lower levels of 
depressive symptomatology displayed greater SBP reactivity to the TSST compared to 
those with higher levels of symptomatology (F (1, 37) = 4.72, p = .036, η2 = .11); see 
Figure 1.  There was neither a significant difference in SBP reactivity or recovery 
between levels of depression in either the ACT or Control conditions nor a significant 
difference in SBP between groups at a given level of depression at any time point (p’s > 
.1); See Figures 2-5.  Once relevant covariates (drug use, alcohol, gender, BMI, time of 
day, experimenter) were controlled for along with baseline SBP, the 3-way interaction 
was no longer significant (p = .06).  
 For DBP, repeated measures ANCOVAs, with total BDI-II score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.9, 330.07) = 19.56, p 
≤  0.001, η2 = .15) as well as a time by group interaction (F (5.79, 330.07) = 73.09, p = 
.047, η2 = .02). Post hoc tests indicate a group difference in DBP at baseline among the 
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AT and Control groups (p = .001).  Once baseline DBP was controlled for, no main or 
interaction effects were observed.  Similarly, controlling for relevant covariates (drug 
use, smoker, BMI, time of day, experimenter), along with baseline DBP, did not result in 
any significant effects. 
 Anxiety Sensitivity (Anxiety Sensitivity Index). For HR, repeated measures 
ANCOVAs, with total ASI score entered as a covariate to test for moderation, revealed a 
main effect of time (F (2.28, 259.3) = 5.16, p = .004, η2 = .04).  Controlling for baseline 
HR revealed no main or interaction effects.  However, once relevant covariates (exercise, 
time of day, experimenter) were controlled for along with baseline HR, a main effect of 
time reemerged (F (1.9, 208.64) = 3.13, p = .048, η2 = .03), indicating a significant 
change in HR over time. 
 For SBP, repeated measures ANCOVAs, with total ASI score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.86, 326.06) = 16.96, 
p ≤ 0.001, η2 = .13).  Once baseline SBP was added as a covariate, however, no main or 
interaction effects were observed.  Similarly, controlling for relevant covariates (drug 
use, alcohol, gender, BMI, time of day, experimenter), along with baseline SBP, did not 
result in any significant effects. 
 For DBP, repeated measures ANCOVAs, with total ASI score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.89, 329.12) = 7.54, p 
≤ 0.001, η2 = .06).  Once baseline DBP was controlled for, however, no main or 
interaction effects were observed.  Similarly, controlling for relevant covariates (drug 
use, smoker, BMI, time of day, experimenter), along with baseline DBP, did not result in 
any significant effects. 
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 Social Anxiety (Liebowitz Social Anxiety Scale). For HR, repeated measures 
ANCOVAs, with total LSAS score entered as a covariate to test for moderation, revealed 
a main effect of time (F (2.3, 255.01) = 9.18, p ≤ 0.001, η2 = .08). Controlling for baseline 
HR revealed no main or interaction effects. However, once relevant covariates (exercise, 
time of day, experimenter) were controlled for along with baseline HR, a main effect of 
time reemerged (F (1.92, 205.01) = 5.02, p = .008, η2 = .05), indicating a significant 
change in HR over time. 
 For SBP, repeated measures ANCOVAs, with total LSAS score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.9, 322.33) = 10.39, p 
≤ 0.001, η2 = .09) as well as a 3-way time by group by social anxiety interaction (F (5.81, 
322.33) = 2.68, p = .016, η2 = .05).  This 3-way interaction remained after controlling for 
baseline SBP (F (3.91, 214.86) = 3.46 p = .01, η2 = .06) and after controlling for relevant 
covariates (drug use, alcohol, gender, BMI, time of day, experimenter) along with 
baseline SBP (F (3.9, 200.77) = 3.8 p = .006, η2 = .07); See Figures 6-10.  The 3-way 
interaction demonstrates that across time points, SBP is affected differently among 
intervention groups depending on level of social anxiety.  In the AT group, individuals 
with lower levels of social anxiety symptomatology recovered less after the TSST than 
those with higher levels of symptomatology (F (1, 37) = 6.17, p = .018, η2 = .14); see 
Figure 6.  At time 4, there was a significant difference in SBP between levels of social 
anxiety symptomatology in the AT group (F (1, 37) = 5.13, p = .029, η2 = .12); see Figure 
6.  There was neither a significant difference in SBP reactivity or recovery between levels 
of social anxiety in either the ACT or Control conditions nor a significant difference in 
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SBP between groups at a given level of social anxiety at any time point (p’s > .1); see 
Figures 7-10. 
 For DBP, repeated measures ANCOVAs, with total LSAS score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.88, 320.10) = 10.0, p 
≤ 0.001, η2 = .08) as well as a 3-way time by group by social anxiety interaction (F (5.77, 
320.1) = 2.34, p = .034, η2 = .04).  This 3-way interaction remained after controlling for 
baseline DBP (F (3.92, 215.75) = 2.7, p= .032, η2 = .05); see Figures 11-15.  The 3-way 
interaction demonstrates that across time points, DBP is affected differently among 
intervention groups depending on level of social anxiety.  In the AT group, individuals 
with lower levels of social anxiety symptomatology recovered less after the TSST than 
those with higher levels of symptomatology (F (1, 37) = 4.38, p = .043, η2 = .11); see 
Figure 11.  There was neither a significant difference in DBP reactivity or recovery 
between levels of social anxiety in either the ACT or Control conditions nor a significant 
difference in DBP between groups at a given level of social anxiety at any time point (p’s 
> .1); see Figures 12-15.  Once relevant covariates (drug use, smoker, BMI, time of day, 
experimenter) were controlled for along with baseline DBP, the 3-way interaction was no 
longer significant (p = .056).  
 Trait Anxiety (Spielberger State Trait Anxiety Inventory- Trait). For HR, 
repeated measures ANCOVAs, with total STAI-Trait score entered as a covariate to test 
for moderation, revealed no main or interaction effects.  Similarly, controlling for 
baseline HR, no main or interaction effects were observed.  However, once relevant 
covariates (exercise, time of day, experimenter) were controlled for along with baseline 
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HR, a main effect of time was emerged (F (1.91, 209.54) = 3.34, p = .039, η2 = .03), 
indicating a significant change in HR over time. 
 For SBP, repeated measures ANCOVAs, with total STAI-Trait score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.85, 324.61) = 5.71, p 
= .001, η2 = .05).  Once baseline SBP was added as a covariate, however, no main or 
interaction effects were observed.  Similarly, controlling for relevant covariates (drug 
use, alcohol, gender, BMI, time of day, experimenter), along with baseline SBP did not 
result in any significant effects. 
 For DBP, repeated measures ANCOVAs, with total STAI-Trait score entered as a 
covariate to test for moderation, revealed a main effect of time (F (2.88, 328.36) = 4.17, p 
= .007, η2 = .04).  Once baseline DBP was controlled for, however, no main or interaction 
effects were observed.  Similarly, controlling for relevant covariates (drug use, smoker, 
BMI, time of day, experimenter), along with baseline DBP and STAI-Trait did not result 
in any significant effects. 
Hypothesis 1b: Association of Depressive and Anxiety Symptoms with 
Cardiovascular Reactivity and Recovery 
 Partial correlations, with group as covariate, revealed no associations between 
depression (as measured by total score on the BDI-II) and HR, SBP, or DBP reactivity or 
recovery.  Additionally, no associations were found between social anxiety (as measured 
by total score on the LSAS) or trait anxiety (as measured by total score on the STAI-
Trait) and HR, SBP, or DBP reactivity or recovery.  However, HR reactivity was found 
to be positively associated with anxiety sensitivity (as measured by total score on the 
ASI) (pr = .21, p = .027).  No associations were observed between HR recovery and ASI.   
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Discussion 
Purpose of the Present Study 
 Stress is a psychosocial risk factor that has long been linked to medical illness and 
various psychopathologies (Kessler, 1997; McEwen, 2003; Nugent et al., 2011).  While it 
has been well established that behavioral factors (e.g., diet, exercise, substance use) play 
a critical role in the onset and maintenance of stress-related illness, the role of internal 
biological mechanisms of stress are less understood (Luthar, 2003; McEwen, 2000).  As 
discussed throughout the introduction, the concepts of allostasis and allostatic load offer a 
useful framework for investigating the psychobiological mechanisms affected by stress, 
particularly those involving the cardiovascular system (McEwen & Stellar 1993; Sterling 
& Eyer, 1988). 
 In our study we set out to examine cardiovascular stress reactions to an acute 
psychosocial stressor and were particularly interested in investigating whether brief 
psychosocial interventions would attenuate these reactions.  As previously mentioned, 
although responses to stressors in a laboratory setting may not be of great clinical 
importance, they indicate how a person responds to stressful demands in their everyday 
life and offer a useful way to examine disturbed stress responses that may have 
pathological consequences (Chida & Hamer, 2008; Salomon et al., 2009).  Additionally, 
laboratory settings provide a controlled environment whereby direct physiological 
outcomes to clinical interventions can be validly acquired.  Another aim of our study was 
to explore how certain psychological symptoms (e.g., anxiety and depressive 
symptomatology) influence acute physiological stress reactions and whether these 
symptoms moderate the treatment response to brief interventions.  Given the current 
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discrepancy among the literature in regards to how psychosocial factors affect the stress 
response, we believe this aim offers important implications for clinical assessment and 
intervention.  
 To our knowledge, this is the first study to examine the effects brief clinical 
interventions have on cardiovascular reactions (e.g., heart rate, systolic blood pressure, 
diastolic blood pressure) to an acute psychosocial stress paradigm, and whether common 
psychosocial factors (e.g., anxiety and depression) moderate the treatment response. 
Hypothesis 1 
 In our study, participants were randomized to one of three intervention conditions. 
The first experimental condition was developed based on Acceptance and Commitment 
Therapy (ACT), a therapeutic approach that focuses on increasing one’s flexibility and 
willingness to accept stressful and anxiety provoking events and feelings (Hayes et al., 
1999).  ACT has proven empirical evidence for its effectiveness in treating a variety of 
psychopathologies, including depression and anxiety, and has been shown to affect 
positive cardiovascular outcomes (Cambell-Sills et al., 2008; Forman et al., 2007; Hayes 
et al., 2004; Low et al., 2008; Woods et al., 2006; Zettle, 2003; Zettle & Hayes, 1986; 
Zettle & Rains, 1989).  
 The second experimental condition was Autogenic Training (AT), a self-
relaxation procedure that involves a series of statements aimed at reducing autonomic 
arousal (Linden, 1990).  AT has shown clinical main effects in the range of medium-to-
large effect sizes in both nonclinical and clinical populations. For example, a number of 
studies have shown AT to be a beneficial for the reduction of anxiety and depressive 
symptoms, as well as a variety of cardiovascular outcomes, such as heart rate and blood 
BRIEF CLINICAL INTERVENTIONS     39  
pressure (Kanji, 2004a; Kanji, 2004b; Krampen, 1999, Farne & Gnugnoli, 2000; Stetter 
& Kupper, 2002).  The third condition, an Attention-only Control group, involved joining 
with a research assistant to read an interactive adventure book. 
 Based on literature demonstrating the positive benefits relaxation and acceptance 
techniques have on health outcomes, we hypothesized that brief interventions would have 
differential effects on heart rate, systolic blood pressure, and diastolic blood pressure 
following a psychosocial stress paradigm.  Specifically, we thought the ACT and AT 
experimental conditions would attenuate the stress response, resulting in positive 
cardiovascular outcomes (e.g., lower reactivity and greater recovery following the TSST).  
Further, because we were measuring acute physiological outcomes, we hypothesized that 
the AT condition, being a somatic relaxation technique, would be superior to the ACT 
condition, and that both experimental conditions would be superior to the Attention-only 
Control condition.  In support of our hypothesis, results showed a time by group 
interaction for heart rate and diastolic blood pressure, indicating that brief interventions 
differentially affected heart rate and diastolic blood pressure over time.  However, after 
controlling for relevant covariates, particularly baseline differences in heart rate and 
diastolic blood pressure, these effects were no longer evident.  Additionally, contrary to 
our hypothesis, we did not observe any effects on systolic blood pressure.  
 One way of interpreting our results is to suggest that the original time by group 
interactions for both heart rate and diastolic blood pressure were driven by baseline 
differences between groups.  However, another interpretation is that intervention effects, 
which could no longer be measured after controlling for baseline time points, drove our 
results.  For example, in regards to heart rate outcomes, there was a greater reduction in 
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heart rate from baseline to pre-TSST in the AT group compared to the ACT and Control 
groups.  This suggests that there was a greater intervention effect for the AT group 
compared to the other groups.  However, because we had to control for baseline 
differences in subsequent analyses, and therefore remove time 1, the intervention effect 
could no longer be displayed.  Therefore, it may be that the observed time by group 
interaction was in fact due to the AT intervention effect rather than baseline differences 
in heart rate. 
 In regards to diastolic blood pressure, the same interpretations must be 
considered.  Again, it may be that the group by time interaction was driven by baseline 
differences in diastolic blood pressure.  However, another possibility is that intervention 
effects, which could no longer be measured after controlling for baseline time points, 
drove our results.  On further examination, the AT group again showed a significant 
intervention effect compared to the ACT and Control groups, which was evidenced by a 
lowering of diastolic blood pressure from baseline to pre-TSST. However, because we 
had to control for baseline differences in subsequent analyses, and therefore remove time 
1, this effect could no longer be demonstrated.  Therefore, as with heart rate, it may be 
that the intervention effects of the AT group rather than baseline differences in diastolic 
blood pressure drove the observed time by group interaction. 
Hypothesis 1a 
 Our second hypothesis was that anxiety and depressive symptomatology would 
moderate the treatment response.  This hypothesis was more exploratory in nature since 
there is no literature, to our knowledge, investigating whether psychosocial factors 
moderate cardiovascular outcomes to brief clinical interventions.  
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 We hypothesized that anxiety and depression levels would moderate the treatment 
response to brief clinical interventions.  In regards to depressive symptomatology and 
systolic blood pressure, our hypotheses were supported.  Results showed a significant 
three-way interaction indicating that across time points, SBP was affected differently 
among intervention groups depending on level of depression.  Within the Autogenic 
Training group, subjects with higher levels of depressive symptomatology had lower SBP 
reactivity to the TSST than those with less symptomatology.  There were no significant 
differences between levels of depression in SBP reactivity, recovery, or across any time 
points within either the ACT or Control conditions.  This finding provides evidence that 
AT may be most beneficial for individuals with higher levels of depression.  Once 
relevant covariates were controlled for, the three-way interaction was no longer 
significant (p = .06).  
 In regards to social anxiety symptomatology and systolic and diastolic blood 
pressure, our hypotheses were also supported.  Results showed a significant three-way 
interaction indicating that across time points, after controlling for all relevant covariates, 
SBP was affected differently among intervention groups depending on level of social 
anxiety.  Within the AT group, subjects with higher levels of social anxiety 
symptomatology had greater SBP recovery following the TSST than those with less 
symptomatology.  Additionally, within the AT group, subjects with higher levels of 
social anxiety symptomatology had significantly lower SBP than those with less 
symptomatology at time 4.  There were no significant differences between levels of social 
anxiety in SBP reactivity, recovery, or across any time points within either the 
Acceptance and Commitment Therapy or Control conditions. Overall, this finding 
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provides evidence that AT may be most beneficial for individuals with higher levels of 
social anxiety.  
 Additionally, results showed a significant three-way interaction indicating that 
across time points, DBP is affected differently among intervention groups depending on 
level of social anxiety.  This finding held after controlling for baseline differences in 
diastolic blood pressure.  Within the AT group, subjects with higher levels of social 
anxiety symptomatology had greater DBP recovery following the TSST than those with 
less symptomatology.  There were no significant differences between levels of social 
anxiety in DBP reactivity, recovery, or across any time points within either the ACT or 
Control conditions.  This finding also provides evidence that AT may be beneficial for 
individuals with higher levels of social anxiety.  However, once other relevant covariates 
were controlled for along with baseline DBP, the three-way interaction was no longer 
significant (p = .056).  
 In sum, our results show that depressive and social anxiety symptomatology 
moderated the effectiveness of our brief clinical interventions, as measured by 
cardiovascular outcomes.  Analyzing these findings together it is evident that subjects 
with greater levels of social anxiety and those with greater levels of depressive symptoms 
benefited more from the Autogenic Training intervention than those with lower levels.  It 
is an interesting finding that individuals with higher levels of psychopathology showed 
greater cardiovascular benefits from AT.  Because the intervention was brief, and 
therefore less potent than if it had been practiced on several occasions, some may have 
expected individuals with lower levels of psychopathology to benefit the most from it. 
 One interpretation for our findings is that nonclinical subjects with greater social 
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anxiety (and depression) were more motivated to participate in the intervention, and thus, 
learned and benefited more from it, thereby affecting cardiovascular outcomes.  There is 
a vast literature on the importance of motivation for the acquisition and transfer of 
techniques and skills taught in psychosocial interventions (see Ryan et al., 2011 for a 
review).  In fact, motivation has been found to be so important for learning and transfer 
that an empirically supported directive therapeutic style, Motivational Interviewing, has 
been developed to focus on helping patients increase it (Miller, 1983; Miller & Rollnick, 
1991; Miller & Rollnick, 2002; Hettema, Steele, & Miller, 2005).  Based on motivational 
theories (e.g., Self-Determination Theory; Deci & Ryan, 1985), it is reasonable that 
individuals with greater intrinsic motivation, perhaps those with more symptoms of 
psychopathology, would be more likely to fully engage in a brief version of Autogenic 
Training, which is directly aimed at reducing the symptoms they are experiencing.    
Hypothesis 1b 
 As discussed in the introduction, current research has shown mixed results for the 
effects depression and anxiety have on physiological stress reactions.  For example, 
studies investigating physiological responses to acute psychosocial stressors have 
suggested that depression and anxiety are related to enhanced cardiovascular reactivity, 
as evidenced by increased blood pressure and heart rate (de Rooij et al., 2010; Kibler & 
Ma, 2004; Mausbach et al., 2005).  However, other researchers have found negative 
associations implicating a hyporeactivity to acute psychosocial stress (Carroll et al., 
2007; Jezova et al., 2004; Salomon et al., 2009).  In addition, it is important to note that 
there is a lack of research investigating the relationship between depressive and anxiety 
BRIEF CLINICAL INTERVENTIONS     44  
symptomatology and cardiovascular recovery, rather most studies concentrate on 
reactivity.  
 Our study design offered an opportunity for us to add to the literature regarding 
the possible associations between certain key psychosocial factors and cardiovascular 
reactivity and recovery.  Based on prior research, we hypothesized that after controlling 
for treatment group, anxiety and depressive symptomatology would be associated with 
greater cardiovascular reactivity and lower recovery following the TSST.  Our hypothesis 
was partially supported in that heart rate reactivity was found to be positively associated 
with anxiety sensitivity (as measured by total score on the ASI).  However, no additional 
measures were associated with any other cardiovascular parameters. 
 In our study, mean scores for all four measures (BDI-II, ASI, LSAS, STAI-Trait) 
were all in the nonclinical range.  Therefore, one interpretation of these results is that 
certain associations were not observed because our study included a nonclinical 
population that displayed subthreshold symptomatology.  Our results imply that lower 
levels of psychopathology (i.e., a few symptoms of anxiety or depression), although 
meaningful, may not affect physiological parameters as drastically as more severe 
pathology.  
 In further discussion of our results, we did not specifically study individual 
differences in regards to psychopathology.  For example, a biological predisposition to 
certain disorders may engender more physiological effects.  Additionally, certain 
symptoms of anxiety and depression may elicit cardiovascular responses (e.g., 
somatic/physical symptoms) more than others (e.g., cognitive/affective symptoms).  It is 
also reasonable to ascertain that age of onset and length of time experiencing certain 
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pathology may have more or less of an effect on physiological parameters.  
Unfortunately, because we did not directly study these types of individual differences, we 
were not able to test these possibilities.  Therefore, one important implication of our 
study is that direct consideration of individual differences when investigating 
physiological outcomes is imperative.  
Limitations 
 Although there are many strengths of this study, such as its novelty, there are 
some important limitations to mention.  First, although our subjects were randomly 
assigned to groups, there were still baseline differences in two of three cardiovascular 
parameters.  This indicates that our baseline data might represent anticipation stress 
rather than a true baseline condition.  Therefore, future research utilizing a similar study 
design should take baseline anticipation stress into consideration by adequately 
measuring and treating it as a confounding factor.  Second, we did not measure 
cardiovascular parameters during the TSST; rather we assessed reactivity immediately 
following the cessation of the protocol.  Although this method has been utilized in 
various studies, assessing cardiovascular parameters during the TSST may provide a 
more valid measure of reactivity.  Third, because of our sample population and sample 
size of men, we were not able to investigate possible age and gender differences in 
treatment response.  Several studies (e.g., Kelly, Tyrka, Anderson, Price, Carpenter, 
2008; Kudielka et al, 2004a) have found age and gender differences in responses to social 
stress challenges.  Therefore, exploring age and gender differences in treatment response 
involving objective outcome measures is warranted.  Lastly, we did not directly measure 
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motivation and treatment engagement, which can both be considered as possible 
confounds decreasing intervention effectiveness. 
Future Directions 
 There is a growing awareness of the detrimental health effects stress has on 
individuals.  This awareness has led to research endeavors investigating the exact 
pathways linking stress and health.  Just as important as elucidating these mechanisms, 
there is also a need for the development and study of specific interventions to counteract 
the effects of stress.  Our study has specifically added to this field by showing that brief 
clinical interventions involving somatic relaxation, particularly Autogenic Training, may 
be beneficial to individuals undergoing acute stress.  Additionally, our study 
demonstrated that individuals with higher levels of depression and/or anxiety might 
benefit the most from these targeted interventions.  
 Particularly within the field of behavioral medicine, our findings offer important 
implications for assessment and treatment.  Acute physiological reactivity from stressful 
medical and dental procedures is common and may lead to negative outcomes (Cohen, 
Fiske, & Newton, 2000; Johnsen et al., 2003; Munafo & Stevenson, 2001; Mavros et al., 
2011; Pignay-Demaria, Lesperance, Demaria, Frasure-Smith, & Perrault, 2003).  
Moreover, it is well evidenced that mild and severe forms of anxiety and depressive 
disorders are high in medical and dental patient populations and are considered risk 
factors for disease (Demertizis & Craske 2006; Moussavi et al., 2007; Sherbourne, 
Jackson, Meredith, Camp, & Wells, 1996; Stoudemire, 1996; Wittchen et al., 2002).  
Targeting certain individuals more prone to poor outcomes (e.g., those suffering from 
mild or severe psychopathology) and administering brief clinical interventions prior to 
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stressful procedures may attenuate and/or prevent negative health outcomes.  Future 
research investigating the effectiveness brief clinical interventions have on these 
populations is not only warranted, but highly feasible.   
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Appendix A. Diagram of Participant Involvement in Larger Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Time 2 (~45 mins) 
 
Pre-Trier Assessment 
(~30 mins) 
    -Physiological  
     Measures 
    -Process Measures 
 
Trier Social Stress Test 
(~15 mins) 
    -Instructions 
    -Anticipation 
    -Free Speech 
    -Subtraction 
Time 3 (~60 mins) 
 
Post-Trier Assessment 
(~20 mins) 
    -Physiological 
     Measures 
    -Process Measures 
 
Debriefing (~15 mins) 
 
Rest Period (~15 mins) 
    -Physiological  
     Measures 
 
Wrap Up (~10 mins) 
    -Questions 
 
Time 1 (~75 mins) 
 
Informed Consent 
(~15 mins) 
 
Baseline Assessment (~40 
mins) 
   -Physiological   
    Measures 
   -Psychological     
    Measures 
 
Intervention Sessions 
(~20 mins) 
    -Group 1: ACT 
    -Group 2: AT 
    -Group 3: Control 
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Table 1 
 
Participant Characteristics by Group 
 ACT AT Control Total n 
 
n 
 
40 
 
40 
 
40 
 
120 
 
120 
 
Age (SD) 
 
19.32 (1.16) 
 
18.95 (.90) 
 
18.95 (.96) 
 
19.08 (1.02) 
 
120 
Mental Health 
Condition (%) 6 (15%) 8 (20%) 3 (7.5%) 17 (14.2%) 120 
Medical  
Condition (%) 2 (5%) 4 (10%) 3 (7.5%) 9 (7.5%) 120 
 
Daily Medication 
(%) 
 
12 (30%) 
 
11 (27.5%) 
 
10 (25%) 
 
33 (27.5%) 
 
120 
 
Illicit Drug Use 
(%)b,c 
 
7 (17.5%) 
 
5 (12.5%) 
 
4 (10%) 
 
16 (13.3%) 
 
120 
 
Cigarette Smoker 
(%) 
 
2 (5%) 
 
4 (10%) 
 
0 
 
6 (5%) 
 
120 
BMI (kg/m2)b,c 23.73 (4.59) 23.16 (3.83) 23.43 (3.67) 23.44 (4.03)  119 
Physical Exercise 
(%)a 
 
21 (52.5%) 
 
23 (57.5%) 22 (55%) 66 (55%) 120 
Race and Ethnicity 
White 
Black 
Asian 
Hispanic    
Biracial/Multiracial 
 
25 (62.5%) 
5 (12.5%) 
4 (10%) 
6 (15%) 
0 
 
28 (70%) 
5 (12.5%) 
6 (15%) 
1 (2.5%) 
0 
 
26 (65%) 
3 (7.5%) 
4 (10%) 
5 (12.5) 
2 (5%) 
 
79 (65.8%) 
13 (10.8%) 
14 (11.7%) 
12 (10%) 
2 (1.7%) 
 
120 
 
 
Consume Alcohol 
(%)b 
 
22 (55%) 
 
23 (57.5%) 
 
24 (60%) 
 
69 (67.5%) 
 
120 
 
Time of Daya 
AM (9-12 PM) 
Early PM (12-3 PM) 
Late PM (3-6 PM) 
 
16 (40%) 
9 (22.5%) 
15 (37.5%) 
 
8 (20%) 
22 (55%) 
10 (25%) 
 
11 (27.5%) 
15 (37.5) 
14 (35%) 
 
35 (29.2%) 
46 (38.3%) 
39 (32.5) 
120 
aCorrelates with baseline HR (p ≤ 0.1); bCorrelates with baseline SBP (p ≤ 0.1); 
cCorrelates with baseline DBP (p ≤ 0.1) 
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Table 2 
 
Participant Characteristics by Gender 
 Male Female All n 
 
n 
 
40 
 
80 
 
120 
 
120 
 
Age (SD) 
 
18.98 (1.03) 
 
19.13 (1.02) 
 
19.08 (1.02) 
 
120 
Mental Health 
Condition (%) 
 
3 (7.5%) 
 
14 (17.5%) 
 
17 (14.2%) 
 
120 
Medical  
Condition (%) 
 
2 (5.0%) 
 
7 (8.8%) 
 
9 (7.5%) 
 
120 
 
Daily Medication (%) 
 
6 (15.0%) 
 
27 (33.8%) 
 
33 (27.5%) 
 
120 
 
Illicit Drug Use (%)b,c 
 
9 (22.5%) 
 
7 (8.8%) 
 
16 (13.3%) 
 
120 
 
Cigarette Smoker (%) 
 
2 (5.0%) 
 
4 (5.0%) 
 
6 (5.0%) 
 
120 
BMI (kg/m2)b,c  23.55 (4.04) 
 
23.39 (4.04) 
 
23.44 (4.02) 
 
119 
Physical Exercise (%)a  26 (65.0%) 
 
40 (50.0%) 
 
66 (55.0%) 
 
120 
Race and Ethnicity 
White 
Black 
Asian 
Hispanic 
    Biracial/Multiracial 
 
30 (75.0%) 
2 (5.0%) 
6 (15.0%) 
1 (2.5%) 
1 (2.5%) 
 
51 (63.75%) 
13 (16.25%) 
8 (10.0%) 
7 (8.75%) 
1 (1.25%) 
 
81 (67.5%) 
15 (12.5%) 
14 (11.7%) 
8 (6.6%) 
2 (1.6%) 
120 
 
 
Consume Alcohol (%)b 
 
26 (65.0%) 
 
43 (53.8%) 
 
69 (57.5%) 
 
120 
 
Time of Daya 
AM (9-12 PM) 
Early PM (12-3 PM) 
Late PM (3-6 PM) 
 
 
12 (30%) 
16 (40%) 
12 (30%) 
 
 
 
23 (28.7%) 
30 (37.5%) 
27 (33.8%) 
 
 
35 (29.2%) 
46 (38.3%) 
39 (32.5%) 
 
 
 
120 
aCorrelates with baseline HR (p ≤ 0.1); bCorrelates with baseline SBP (p ≤ 0.1); 
cCorrelates with baseline DBP (p ≤ 0.1) 
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Table 3 
 
Descriptive Statistics for Study Measures by Group 
 Mean SD N 
Heart Rate (bpm)    
Baseline Total 
ACT Group 
AT Groupa 
Control Group 
76.47 
73.6 
81.78 
74.03 
14.72 
12.11 
13.96 
16.61 
120 
40 
40 
40 
Pre-TSST Total 
ACT Group 
AT Group 
Control Group 
66.53 
65.83 
67.25 
66.53 
10.56 
9.50 
10.50 
11.78 
120 
40 
40 
40 
Post-TSST Total            
ACT Group 
AT Group 
Control Group 
69.44 
68.10 
70.55 
69.68 
12.11 
9.50 
12.47 
14.10 
120 
40 
40 
40 
Recovery Total 
ACT Group 
AT Group 
Control Group 
67.17 
65.95 
67.72 
67.83 
11.61 
9.36 
12.35 
12.96 
120 
40 
40 
40 
Systolic Blood Pressure (mmHg)    
Baseline Total 
ACT Group 
AT Group 
Control Group 
126.11 
126.05 
129.25 
123.03 
14.60 
13.95 
14.29 
15.22 
120 
40 
40 
40 
Pre-TSST Total 
ACT Group 
AT Group 
Control Group 
120.15 
119.68 
122.60 
118.18 
13.052 
13.0 
14.25 
11.73 
120 
40 
40 
40 
Post-TSST Total           
ACT Group 
AT Group 
Control Group 
131.38 
130.38 
134.88 
128.90 
14.36 
12.52 
15.73 
14.33 
120 
40 
40 
40 
Recovery Total 
ACT Group 
AT Group 
Control Group 
123.98 
123.73 
127.0 
121.20 
13.891 
11.85 
15.82 
13.44 
120 
40 
40 
40 
Diastolic Blood Pressure (mmHg)    
Baseline Total 
ACT Group 
AT Groupb 
Control Group 
72.97 
73.05 
76.43 
69.45 
8.90 
8.17 
8.57 
8.76 
120 
40 
40 
40 
Pre-TSST Total 
ACT Group 
AT Group 
70.39 
70.05 
71.28 
8.83 
7.79 
8.98 
120 
40 
40 
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Control Group 69.85 9.78 40 
Post-TSST Total             
ACT Group 
AT Group 
Control Group 
78.59 
79.65 
79.13 
77.0 
8.14 
7.59 
7.96 
8.78 
120 
40 
40 
40 
Recovery Total 
ACT Group 
AT Group 
Control Group 
73.39 
73.56 
74.3 
72.33 
8.58 
8.61 
8.86 
8.37 
120 
40 
40 
40 
Beck Depression Inventory II     
Baseline Measure Total 
ACT Group 
AT Group 
Control Group 
8.34 
8.95 
8.68 
7.40 
6.87 
6.70 
7.22 
6.75 
120 
40 
40 
40 
Liebowitz Social Anxiety Scale    
Baseline Measure Total 
ACT Group 
AT Group 
Control Group 
35.50 
37.88 
34.88 
33.60 
21.60 
23.55 
19.32 
22.09 
117 
40 
40 
37 
Spielberger State Trait Anxiety 
Inventory- Trait 
   
Baseline Measure Total 
ACT Group 
AT Group 
Control Group 
38.88 
39.45 
38.75 
38.43 
10.67 
10.27 
10.60 
11.34 
120 
40 
40 
40 
Anxiety Sensitivity Index    
Baseline Measure Total 
ACT Group 
AT Group 
Control Group 
19.65 
19.35 
19.38 
20.23 
9.98 
11.16 
7.90 
10.78 
120 
40 
40 
40 
aStatistically significant difference compared to ACT and Control Groups (p ≤ 0.05); 
bStatistically significant difference compared to Control Group (p ≤ 0.05) 
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Table 4 
 
Descriptive Statistics for Study Measures by Gender 
 Mean SD N 
Heart Rate (bpm)    
Baseline Total 
Male 
Female 
76.47 
75.95 
76.72 
14.72 
16.25 
13.99 
120 
40 
80 
Pre-TSST Total 
Male 
Female 
66.53 
65.62 
66.99 
10.56 
11.18 
10.28 
120 
40 
80 
Post-TSST Total            
Male 
Female 
69.44 
69.95 
69.19 
12.11 
14.03 
11.12 
120 
40 
80 
Recovery Total 
Male 
Female 
67.17 
67.08 
67.21 
11.61 
12.44 
11.25 
120 
40 
80 
Systolic Blood Pressure (mmHg)    
Baseline Total 
Malea 
Female 
126.11 
137.45 
120.44 
14.60 
14.44 
10.97 
120 
40 
80 
Pre-TSST Total 
Malea 
Female 
120.15 
131.35 
114.55 
13.052 
12.64 
9.08 
120 
40 
80 
Post-TSST Total           
Malea 
Female 
131.38 
144.07 
125.04 
14.36 
12.92 
10.29 
120 
40 
80 
Recovery Total 
Malea 
Female 
123.98 
134.18 
118.87 
13.891 
11.70 
12.0 
120 
40 
80 
Diastolic Blood Pressure (mmHg)    
Baseline Total 
Male 
Female 
72.97 
73.97 
72.48 
8.90 
10.74 
7.86 
120 
40 
80 
Pre-TSST Total 
Male 
Female 
70.39 
71.05 
70.06 
8.83 
9.05 
8.76 
120 
40 
80 
Post-TSST Total             
Male 
Female 
78.59 
79.53 
78.13 
8.14 
8.16 
8.14 
120 
40 
80 
Recovery Total 
Male 
Female 
73.39 
73.8 
73.19 
8.58 
10.41 
7.58 
120 
40 
80 
Beck Depression Inventory II     
Baseline Measure Total 
Male 
8.34 
6.98 
6.87 
5.24 
120 
40 
BRIEF CLINICAL INTERVENTIONS     70  
Female 9.03 7.49 80 
Liebowitz Social Anxiety Scale    
Baseline Measure Total 
Male 
Female 
35.50 
32.23 
37.2 
21.60 
18.52 
23.0 
117 
40 
77 
Spielberger State Trait Anxiety 
Inventory- Trait 
   
Baseline Measure Total 
Malea 
Female 
38.88 
36.05 
40.29 
10.67 
9.1 
11.16 
120 
40 
80 
Anxiety Sensitivity Index    
Baseline Measure Total 
Malea 
Female 
19.65 
16.75 
21.1 
9.98 
8.31 
10.46 
120 
40 
80 
aStatistically significant difference compared to Females (p ≤ 0.05) 
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Figure 1 
 
Autogenic Training Group: Depression and Systolic Blood Pressure
Figure 1. This figure helps demonstrate the 3
depression). It represents the measure of systolic blood pressure (mmHg) over time 
between subjects with high and low depressive symptomatology in the Autogenic 
Training group. 
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Figure 2 
 
Acceptance and Commitment Therapy: 
Figure 1. This figure helps demonstrate the 3
depression). It represents the measure of systolic blood pressure (mmHg) over time 
between subjects with high and low 
Commitment Therapy group.
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Figure 3 
 
Control Group: Depression and Systolic Blood Pressure
 
Figure 3. This figure helps demonstrate the 3
depression). It represents the measure of systolic blood pressure (mmHg) over time 
between subjects with high and low depressive symptomatology in the Control group.
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Figure 4 
 
High Depressive Symptomatology: Group and Systolic 
Figure 4. This figure helps demonstrate the 3
depression). It represents the measure of systolic blood pressure (mmHg) over time 
between intervention groups in those with high depressive 
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Figure 5 
 
Low Depressive Symptomatology: Group and Systolic Blood Pressure
 
Figure 5. This figure helps demonstrate the 3
depression). It represents the measure of systolic blood pressure (mmHg) over time 
between intervention groups in those with 
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Figure 6 
 
Autogenic Training Group: Social Anxiety and Systolic Blood Pressure
 
Figure 6. This figure helps demonstrate the 3
anxiety). It represents the measure of systolic blood pressure (mmHg) over time between 
subjects with high and low social anxiety symptomatology in the Autogenic 
group. 
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Figure 7 
 
Acceptance and Commitment Therapy: Social Anxiety and Systolic Blood Pressure
 
Figure 7. This figure helps demonstrate the 3
anxiety). It represents the measure of systolic blood pressure (mmHg) over time between 
subjects with high and low social anxiety symptomatology in the Acceptance and 
Commitment Therapy group.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
-way interaction (time by group by social 
 
  77  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BRIEF CLINICAL INTERVENTIONS
Figure 8 
 
Control Group: Social Anxiety and Systolic Blood 
 
Figure 8. This figure helps demonstrate the 3
anxiety). It represents the measure of systolic blood pressure (mmHg) over time between 
subjects with high and low social anxiety symptomatology in the 
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Figure 9 
 
High Social Anxiety Symptomatology: Group and Systolic Blood 
 
Figure 9. This figure helps demonstrate the 3
anxiety). It represents the measure of systolic blood pressure (mmHg) over time between 
intervention groups in those with high social anxiety 
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Figure 10 
 
Low Social Anxiety Symptomatology: Group and Systolic Blood Pressure
 
Figure 10.This figure helps demonstrate the 3
anxiety). It represents the measure of systolic blood pressure (mmHg) over time between 
intervention groups in those with 
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Figure 11 
 
Autogenic Training: Social Anxiety and Diastolic Blood Pressure
 
Figure 11. This figure helps demonstrate the 3
anxiety). It represents the measure of 
subjects with high and low 
group. 
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Figure 12 
 
Acceptance and Commitment Therapy: Social Anxiety and Diastolic Blood Pressure
Figure 12. This figure helps demonstrate the 3
anxiety). It represents the measure of 
subjects with high and low 
Commitment Therapy group.
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social anxiety symptomatology in the Acceptance and 
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Figure 13 
 
Control Group: Social Anxiety and Diastolic Blood Pressure
Figure 13. This figure helps demonstrate the 3
anxiety). It represents the measure of 
subjects with high and low 
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Figure 14 
 
High Social Anxiety Symptomatology: Group and 
Figure 14. This figure helps demonstrate the 3
anxiety). It represents the measure of 
intervention groups in those with high social anxiety symptomatology.
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Figure 15 
 
Low Social Anxiety Symptomatology: Group and 
Figure 15. This figure helps demonstrate the 3
anxiety). It represents the measure of 
intervention groups in those with 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Diastolic Blood Pressure
-way interaction (time by group by social 
diastolic blood pressure (mmHg) over time between 
low social anxiety symptomatology. 
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